Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Acutaas ChemicalsNSE:ACUTAAS +1.14%69 EV-to-EBIT is 77.04 as of Aug. 09, 2026, which is 75% above its 10-year median of 43.91. GuruFocus rates NSE:ACUTAAS with a GF Score™ of 69/100 and a GF Value™ of ₹1,156.63 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,242 Chemicals companies, Acutaas Chemicals ranks worse than 90.26% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Acutaas Chemicals's Enterprise Value for the quarter that ended in Jun. 2026 was ₹288,694 Mil.
Acutaas Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,473 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutaas Chemicals EV-to-EBIT Related Terms
Acutaas Chemicals EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Acutaas Chemicals's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ACUTAAS vs LIN, SHW, ECL: EV-to-EBIT Comparison
For the Specialty Chemicals subindustry, Acutaas Chemicals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutaas Chemicals EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Acutaas Chemicals's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Acutaas Chemicals's EV-to-EBIT falls into.
Acutaas Chemicals's current Enterprise Value is ₹267,586 Mil.
Acutaas Chemicals's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,473 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutaas Chemicals (NSE:ACUTAAS) has a EV-to-EBIT of 77.04 as of Aug. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Acutaas Chemicals and its competitors. This is 75% above median its historical median of 43.91. Over the past decade, Acutaas Chemicals' EV-to-EBIT has ranged from 29.07 to 80.93. According to the industry distribution chart, Acutaas Chemicals ranks #1121 out of 1242 companies in the Chemicals industry, placing it in the top 90.3%.
Is Acutaas Chemicals' EV-to-EBIT too high?
Acutaas Chemicals' current EV-to-EBIT of 77.04 is 75% above median its 10-year median of 43.91. Over the past 10 years, this metric has ranged from a low of 29.07 to a high of 80.93. The Chemicals industry median EV-to-EBIT is 17.62. Acutaas Chemicals' value of 77.04 is 337.2% above this industry median. Based on the distribution chart, Acutaas Chemicals ranks #1121 out of 1242 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Acutaas Chemicals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, Acutaas Chemicals ranks #1121 out of 1242 companies for EV-to-EBIT. This places Acutaas Chemicals in the lower half of its industry. The industry median EV-to-EBIT is 17.62. Acutaas Chemicals' value of 77.04 is 337.2% above this benchmark. Historically, Acutaas Chemicals' own EV-to-EBIT has ranged from 29.07 to 80.93 over the past decade. While the company's 10-year median is 43.91 vs. the industry median of 17.62, Acutaas Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.62, based on 1,242 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acutaas Chemicals's current EV-to-EBIT of 77.04 is 337.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Acutaas Chemicals and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acutaas Chemicals's current EV-to-EBIT is 77.04, which is 75% above median its own 10-year median of 43.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,156.63, compared to a current price of ₹3,297.90 — trading 185.1% above its estimated fair value. The current EV-to-EBIT is 77.04, which is 75% above median its 10-year median of 43.91 and 337.2% above the Chemicals industry median of 17.62. Acutaas Chemicals' overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current EV-to-EBIT is 77.04 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?
Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued.
The current stock price of ₹3,297.90 is trading 185.1% above its estimated GF Value™ of ₹1,156.63.
GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:ACUTAAS:
EV-to-EBIT: 77.04 (75% above median its 10-year median of 43.91)
GF Value™: ₹1,156.63 vs. price of ₹3,297.90 (185.1% above fair value)
Industry Position: 337.2% above the Chemicals median (#1121 of 1242)
No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
69GF Score
Get the complete analysis for NSE:ACUTAAS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACUTAAS has been successfully added to your 
